Mariner
QNCX icon

Mariner’s Quince Therapeutics QNCX Stock Holding History

Mariner’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28K Buy
+63
New +$12.6K ﹤0.01% 3540
2025
Q4 		– Sell
-612
Closed -$200K – 3754
2025
Q3 		$200K Hold
612
– – ﹤0.01% 3180
2025
Q2 		$202K Hold
612
– – ﹤0.01% 3049
2025
Q1 		$163K Hold
612
– – ﹤0.01% 3069
2024
Q4 		$229K Hold
612
– – ﹤0.01% 2888
2024
Q3 		$95.1K Buy
612
+242
+65% +$34.7K ﹤0.01% 3100
2024
Q2 		$55.6K Hold
370
– – ﹤0.01% 3036
2024
Q1 		$78.5K Hold
370
– – ﹤0.01% 2973
2023
Q4 		$77.8K Sell
370
-5
-1% -$1K ﹤0.01% 2893
2023
Q3 		$84.1K Buy
+375
New +$98K ﹤0.01% 2705

Other funds holding QNCX

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Mariner's QNCX Position: Q1 2026 in Review

Mariner opened a new position in Quince Therapeutics (QNCX) in Q1 2026: 63 shares worth $1.28K. The stake represents ﹤0.01% of the portfolio and ranks #3540 among its holdings. This is a return to the name: Mariner previously reported a position in QNCX as recently as Q3 2025.

Mariner first reported a position in QNCX in Q3 2023 and has held it in 10 quarters since. The position peaked at $229K in Q4 2024. 43 funds tracked by Wall St. Rank hold QNCX as of Q1 2026.

  • Mariner held 63 shares of Quince Therapeutics worth $1.28K as of Q1 2026.
  • Quince Therapeutics was a new Mariner position in Q1 2026.
  • Quince Therapeutics made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #3540 holding.
  • Mariner first reported a position in Quince Therapeutics in Q3 2023 and has held it in 10 quarters since.
  • Mariner's Quince Therapeutics position peaked at $229K in Q4 2024.
  • 43 funds tracked by Wall St. Rank held Quince Therapeutics as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.